Results 11 to 20 of about 1,309,506 (180)

A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting

SAGE Open Medicine, 2018
Objectives: To evaluate the treatment pattern of antiemetic agents used for chemotherapy-induced nausea and vomiting in a tertiary hospital in Saudi Arabia. Methods: Over a period of 7 weeks, all new chemotherapy order sheets were collected and evaluated
Abdulrahman Alamri, Yousef A Alawlah, Yanru Qiao, Junling Wang   +3 more
doaj   +3 more sources

Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline

Journal of Global Oncology, 2017
Purpose: Adherence to international antiemetic prophylaxis guidelines like those of ASCO can result in better control of chemotherapy-induced nausea and vomiting; however, the extent of implementation of such guidelines in India is unknown.
Vijay Patil, Vanita Noronha, Amit Joshi, Purvish Parikh, Atanu Bhattacharjee, Santam Chakraborty, Sunny Jandyal, Vamshi Muddu, Anant Ramaswamy, K. Govinda Babu, Nilesh Lokeshwar, Sachin Hingmire, Nikhil Ghadyalpatil, Shripad Banavali, Kumar Prabhash   +14 more
doaj   +3 more sources

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study

Therapeutics and Clinical Risk Management, 2017
Afsaneh Vazin, Davood Eslami, Ebrahim Sahebi Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran Abstract: Nausea and vomiting (NV) are the most prevalent adverse effects of chemotherapy (CT).
Vazin A, Eslami D, Sahebi E
doaj   +1 more source

Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients

Breast Cancer: Targets and Therapy, 2011
Vicky TC Chan, Winnie YeoDepartment of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, ChinaAbstract: Chemotherapy-induced nausea and vomiting (CINV) continues to be one of the most distressing side effects of ...
Chan VTC, Yeo W
doaj   +1 more source

Evaluation of Antiemetic Consistency in Chemotherapy-Induced Nausea and Vomiting Among NHL Patients in Sana’a, Yemen [PDF]

International Journal of General Medicine
Mohammed Mohammed Battah,1,2 Hadzliana Zainal,1 Doa’a Anwar Ibrahim,2 Nur Hafzan Binti Md Hanafiah,1 Syed Azhar Syed Sulaiman,1 Abdulsalam Halboup1,2 1Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang ...
Battah MM, Zainal H, Ibrahim DA, Hanafiah NHBM, Syed Sulaiman SA, Halboup A   +5 more
doaj   +1 more source

Multi-institutional survey of antiemetic therapy in lung cancer patients treated with carboplatin in Hokushin region

BMC Pulmonary Medicine, 2023
Objective Appropriate monitoring and management of chemotherapy-induced nausea and vomiting (CINV) with prophylactic antiemetics is important for cancer patients.
Takayuki Ide, Yoshikazu Nishino, Tomoya Takiguchi, Shintaro Kanda, Kengo Otsuki, Ryuji Hayashi, Kazuo Yasumoto, Yasuo Hirono, Tomoe Makino, Seiji Yano, Tomonobu Koizumi   +10 more
doaj   +1 more source

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study [PDF]

Korean Journal of Anesthesiology, 2013
BackgroundPostoperative nausea and vomiting (PONV) continues to be a major problem, because PONV is associated with delayed recovery and prolonged hospital stay.
Sung-Hoon Kim, Jeong-Yeon Hong, Won Oak Kim, Hae Keum Kil, Myong-Hwan Karm, Jai-Hyun Hwang   +5 more
doaj   +1 more source

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

BMC Cancer, 2018
Background Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge ...
Janet Hardy, Helen Skerman, Paul Glare, Jennifer Philip, Peter Hudson, Geoffrey Mitchell, Peter Martin, Odette Spruyt, David Currow, Patsy Yates   +9 more
doaj   +1 more source

Acceptability and prescribing adherence to revised antiemetic guidelines in paediatric patients receiving chemotherapy.

, 2011
The objective of this poster presentation is to assess adherence to and acceptability of revised antiemetic prescribing guidelines implemented 20091 and evaluation of use of the patient-specific antiemetic record.
Cooper, G., Neslen, E., Richardson, N, Kinnear, Moira, Brinton, L., Ferguson, J   +5 more
core   +4 more sources

Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019

BMC Pregnancy and Childbirth, 2022
Background Women suffering from severe nausea and vomiting during pregnancy, hyperemesis gravidarum, have poor quality of life and increased risk of potentially fatal maternal and fetal complications.
Hilde Erdal, Lone Holst, Kristine Heitmann, Jone Trovik   +3 more
doaj   +1 more source